[1]
Łukasz Wołowiec, W. Zukow, J. Pęcherz, D. Czaplińska, A. Jaśniak, and G. Grześk, “Modulation of Inflammation in Heart Failure: The Role of Ziltivekimab and Canakinumab”, J Educ Health Sport, vol. 65, p. 55579, Oct. 2024.